Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01429207 · ClinicalTrials.gov registry record

Capturing Parkinson's Disease Medication Side Effects During Daily Activities

A clinical trial, sponsored by Great Lakes NeuroTechnologies.

Completed
Registry status
15
Enrollment target

NCT01429207 is a clinical trial that has completed, run by Great Lakes NeuroTechnologies. The registered enrollment target is 15 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01429207 has completed, sponsored by Great Lakes NeuroTechnologies.

COMPLETED
Registry status
15 participants
Enrollment target

Study Summary

The purpose of the study is to test whether body-worn wireless motion sensors can measure dyskinesias (involuntary movements caused by medications) in individuals with Parkinson disease (PD) independent of voluntary activity being performed and other PD motor symptoms (e.g. tremor).

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2011-08

Sponsor

Great Lakes NeuroTechnologies

17 total trials

What the Registry Record Tells You About NCT01429207

The ClinicalTrials.gov registry entry for NCT01429207 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Great Lakes NeuroTechnologies, which has 17 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01429207 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01429207 about?

NCT01429207 is a clinical study titled "Capturing Parkinson's Disease Medication Side Effects During Daily Activities". The purpose of the study is to test whether body-worn wireless motion sensors can measure dyskinesias (involuntary movements caused by medications) in individuals with Parkinson disease (PD) independent of voluntary activity being performed and other PD motor symptoms (e.g. tremor).

What is the current status of trial NCT01429207?

This trial is currently completed. The enrollment target is 15 participants. The study started on 2011-08.

Who is sponsoring clinical trial NCT01429207?

This trial is sponsored by Great Lakes NeuroTechnologies, which has 17 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.